Lazarus Naturals News
Lazarus Naturals Summer Highlights

1563450042Lazarus-Naturals-Summer-Highlights-Facebook.jpg

From prestigious awards to great reviews, the people and products of Lazarus Naturals are in several great publications this summer. Check our top pieces of press coverage over the last few months.



The Power of Lazarus Naturals


Our social media presence makes an impact in the CBD industry and the numbers prove it. CBD Snapshot mentions Lazarus Naturals in their “CBD Power 100” list of the most influential CBD businesses on social media. We crack the Top 10 for social media engagement and hit No. 4 for digital unique visitors and digital page views.



Best Of Lists


Our products are in several recent gift guides and “Best Of” roundups. Firstly, Benzinga includes us in their list of “10 Best CBD Oils You Can Buy”. The full line of High Potency CBD Tinctures we carry is named “Best Cost-Effective Product” by writer Eric TerBush.


Gifts and Decorative Accessories highlights our CBD Massage Oil in their “Friday Finds”. Senior Editor Alex Herring compiles her favorite CBD products and says our massage oil “helps promote relaxation.” Our 50mg CBD Capsules also opened June with a feature in another top product roundup.



Employee Quotes And Other Great Mentions


Healthline mentions us in a recent story on CBD, calling us “trustworthy” and “firmly established as a quality source.” Leafly calls us out as a company making CBD more affordable for veterans. Our Assistance Program is open to all American veterans and offers a lifetime 60% discount.


Lastly, McCarton Ackerman, our Communications Coordinator, is quoted in Equities on the recent FDA hearings about CBD. He says that “although advocates are urging the FDA to act quickly in crafting regulations around CBD, the FDA wants to see more scientific data and information on the safety, marketing, and sales of these products. They are continuing to accept public comments until early July and will undergo a comprehensive review process of all the information they receive. Investors should note that any significant changes around CBD regulation will likely not occur in the immediate future."

0 Comments